SOMERSET, N.J., Nov. 17, 2008 (GLOBE NEWSWIRE) -- inVentiv Health (NasdaqGS:VTIV - News) is pleased to announce that GeneraMedix Inc., a pharmaceutical company that develops, markets and distributes generic injectable products, has selected inVentiv to deliver integrated strategic marketing and branding services for the corporation. inVentiv will provide a wide range of services for GeneraMedix’s new specialty Epoprostenol therapy, which is used for treatment of hypertension.
